Designing Sustainable High Performance in Business-to-Business Collaborations

Today’s Line Managers

PRECISION MEDICINE

Apoferritin as a Nanocarrier

Drug Substance Scale-up

Artificial Intelligence

DIGITAL TECHNOLOGY IN PHARMA

BIG DATA AND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MANUFACTURING

PHARMA LOGISTICS TRENDS

Get instant access to latest e-book

LATEST NEWSRead more...

23

Aug 2019

Iconic Therapeutics Signs Ophthalmology Option Agreement

Iconic Therapeutics a private biopharmaceutical company focused on novel therapeutics for serious diseases such as cancer and agerelated macular degeneration today announced that the Company has signed an agreement with Novartis that provides Novartis with an option on Iconics ophthalmology program...

23

Aug 2019

Enable Injections Enters into Strategic Partnership with Genentech, a Member of the Roche Group

Enable Injections Inc Enable a company developing and manufacturing investigational wearable infusion devices for combination products today announced it has entered into a development agreement with Genentech a member of the Roche Group The enFuse under development by Enable will enable patientadmi...

22

Aug 2019

Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

Innovent Biologics Inc a worldclass biopharmaceutical company that develops and commercializes high quality medicines today announced that it has entered into a licensing agreement with Eli Lilly and Company Lilly for the development and potential commercialization of oxyntomodulin analog OXM in Chi...

22

Aug 2019

Enteris BioPharma and Cara Therapeutics Enter into Licensing Agreement for Peptelligence® to Advance Development of Oral KORSUVA™

Enteris BioPharma Inc a biotechnology company developing innovative drug products built around its proprietary oral peptide delivery technologies today announced its entry into a definitive licensing agreement with Cara Therapeutics for Enteris Peptelligence technology in the ongoing development of...

press releasesRead more...

23

Aug 2019

Themis Bioscience Announces Exclusive License Agreement and Research Collaboration with MSD to Develop Vaccine Candidates

Themis Bioscience today announced a research collaboration and exclusive license agreement with MSD a Merck Co Inc Kenilworth NJ US company for the research and development of vaccine candidates using Themis measles virus based platform known

23

Aug 2019

Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)

Seelos Therapeutics Inc a clinicalstage biopharmaceutical company is pleased to announce the acceptance of the Investigation New Drug IND application for SLS trehalose by the Food and Drug Administration FDA The FDA has advised Seelos that it may proceed with the proposed clinical trial SLS for Muco...

22

Aug 2019

Rfxcel Will Exhibit at CPhI Middle East & Africa, the Largest Pharmaceutical Event in the Region

Rfxcel the global leader in supply chain track and trace solutions will exhibit at this years CPhI Middle East Africa MEA conference in Abu Dhabi United Arab Emirates The company is cultivating business in the region particularly pertaining to new serialization requirements

22

Aug 2019

ROZLYTREK™ (entrectinib), FDA Approved for Hard-to-Treat NTRK Fusion-Positive Tumors, Available at Biologics by McKesson

Biologics by McKesson an independent specialty pharmacy for oncology and other rare and complex therapeutic areas was selected by Genentech as a specialty pharmacy provider for ROZLYTREK entrectinib for the treatment of hardtotreat and rare NTRK fusionpositive tumors

EventsRead more...

29 - 30

Aug 2019

Pharma Brand Protection & Packaging 2019

Novotel Hotel

03 - 05

Sep 2019

Drug Discovery & Therapy World Congress

Boston

03 - 04

Sep 2019

BioManufacturing 2019

Sheraton Munich Arabellapark Hotel

04 - 06

Sep 2019

3D Tissue Models Summit

Hanson Wade
Hilton Boston Back Bay

04 - 06

Sep 2019

Microbiome Movement - Skin Health and Dermatology

Hanson Wade
The Westin San Diego

04 - 06

Sep 2019

4th Annual 3D Tissue Models Summit

Hilton Boston Back Bay

Eppendorf AG || rAAV Production in Single-Use Vessels

AirBridgeCargo - Air frieght solutions for your Pharma

Swiss World Cargo - Pharmaceuticals & Healthcare

KNOWLEDGE BANK

Interviews

Merck

Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

Articles

Facing the Autoimmune Epidemic Prevention and treatment by novel vaccines

That autoimmune diseases are on the increase worldwide indicates that they are the result of environmental rather than genetic changes Once believed to be a problem affecting only the West new epidemiological data shows that the incidence of autoimmune conditions

Research Insights

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in

Case Studies

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime

Techno Trends

Bayer Launches Breakthrough Therapy AliqopaTM (Copanlisib) for Treatment of Marginal Zone Lymphoma

Bayer launched a breakthrough therapy AliqopaTM Copanlisib for the treatment of Marginal Zone Lymphoma MZL Aliqopa Copanlisib is an intravenous phosphatidylinositolKinase PLK inhibitory activity predominantly

White Papers

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

REDUCTION OF HEALTH COSTS

Since autumn the first package of costcutting measures in Switzerlands healthcare system is being reviewed One of the measures is the socalled refere...

RESEARCH DEVELOPMENT

Academic Ventures and Professional Service Companies

Over the past few decades life science and pharma have been characterised by a series of radical changes that have been at the origin of an impressive...

CLINICAL TRIALS

The Virtual World of Digital Clinical Trials

Emerging technologies have the potential to fundamentally alter how patients engage with and participate in clinical trials Creating a digital strateg...

MANUFACTURING

ADVANCES IN SPRAY DRYING FOR THE IMPROVED DELIVERY OF POORLY SOLUBLE DRUGS

Spray drying is an important unit operation first patented in Essentially the technique involves the pumping of a solution through a nozzle into a dr...

Information Technology

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

was the year where pharma realised that Big Data could dramatically increase the value of data produced during drug development or coming from Electr...

EXPERT Talk

The Pharmaceutical Supply Chain from a CDMO’s Perspective

The primary change we see is that of market dynamics and rapid growth resulting in an increased complexity in the supply chain In an era of globalisat...

Designing Sustainable High Performance in Business-to-Business Collaborations

Today’s Line Managers

PRECISION MEDICINE

Apoferritin as a Nanocarrier

Drug Substance Scale-up

Artificial Intelligence

DIGITAL TECHNOLOGY IN PHARMA

BIG DATA AND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MANUFACTURING

PHARMA LOGISTICS TRENDS

Get instant access to latest e-book

LATEST NEWSRead more...

23

Iconic Therapeutics Signs Ophthalmology Option Agreement

23

Enable Injections Enters into Strategic Partnership with Genentech, a Member of the Roche Group

22

Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

22

Enteris BioPharma and Cara Therapeutics Enter into Licensing Agreement for Peptelligence® to Advance Development of Oral KORSUVA™

press releasesRead more...

23

Themis Bioscience Announces Exclusive License Agreement and Research Collaboration with MSD to Develop Vaccine Candidates

23

Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)

22

Rfxcel Will Exhibit at CPhI Middle East & Africa, the Largest Pharmaceutical Event in the Region

22

ROZLYTREK™ (entrectinib), FDA Approved for Hard-to-Treat NTRK Fusion-Positive Tumors, Available at Biologics by McKesson

EventsRead more...

29 - 30

Pharma Brand Protection & Packaging 2019

03 - 05

Drug Discovery & Therapy World Congress

03 - 04

BioManufacturing 2019

04 - 06

3D Tissue Models Summit

04 - 06

Microbiome Movement - Skin Health and Dermatology

04 - 06

4th Annual 3D Tissue Models Summit

Advertisements

TOP ARTICLES

1

Bio-Inspired Nanomedicine An Emerging Trend For Drug Targeting Into Cancer Cells

2

Sunlight Assisted Degradation of Waste Chemicals Green Technology for Pharmaceutical Waste Management

3

Ligand Decorated Theranostic Nanomedicines

4

Industry 4.0: A Closed Micronisation System

5

Nanomedicines management for advance therapy of NeuroAIDS: State of art

KNOWLEDGE BANK

Merck

Facing the Autoimmune Epidemic Prevention and treatment by novel vaccines

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

Bayer Launches Breakthrough Therapy AliqopaTM (Copanlisib) for Treatment of Marginal Zone Lymphoma

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Advisory Board

EDITORIAL SECTION

REDUCTION OF HEALTH COSTS

Academic Ventures and Professional Service Companies

The Virtual World of Digital Clinical Trials

ADVANCES IN SPRAY DRYING FOR THE IMPROVED DELIVERY OF POORLY SOLUBLE DRUGS

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

The Pharmaceutical Supply Chain from a CDMO’s Perspective